Dr. Reddy's Recalls Sapropterin Dihydrochloride Powder For Oral Solution

RTTNews | 553 days ago
Dr. Reddy's Recalls Sapropterin Dihydrochloride Powder For Oral Solution

(RTTNews) - Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level.

According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

The product is indicated to reduce blood phenylalanine (Phe) levels in adult and pediatric patients one month of age and older with hyperphenylalaninemia or HPA due to tetrahydrobiopterin-(BH4-) responsive Phenylketonuria (PKU).

Reduced efficacy of the product would result in elevated Phenylalaninemia or Phe levels in patients. Chronically elevated Phe levels in infants and children may cause permanent neurocognitive deficits, and elevated Phe levels during pregnancy, especially in early gestation, are associated with microcephaly and congenital heart disease.

The issue was discovered during an accelerated stability test in addition to customer complaints.

However, Dr. Reddy's has not received any reports of adverse events related to the recall so far.

The impacted drug is packaged in individual packets, 30 per carton. The affected drugs include Javygtor Powder for Oral Solution 100 mg with lot mumbers T2202812, T2204053, T2300975, T2300976, and T2304356; as well as Sapropterin Dihydrochloride Powder for Oral Solution 100 mg with lot code T2200352.

The product was distributed nationwide to wholesalers/retailers.

Dr. Reddy's is notifying its distributors and customers and is arranging for returns of all recalled products.

For More Such Health News, visit rttnews.com

read more
Dr. Reddy's Labs Recalls Levetiracetam In Sodium Chloride Injection

Dr. Reddy's Labs Recalls Levetiracetam In Sodium Chloride Injection

Dr. Reddy's Laboratories Ltd. is recalling Levetiracetam in 0.75% Sodium Chloride Injection in the United States citing mislabeling of infusion bag, according to the U.S. Food and Drug Administration. The recall involves one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level.
RTTNews | 229 days ago
Swiss Market Ends On Weak Note

Swiss Market Ends On Weak Note

After spending a few minutes in positive territory at the start, Switzerland stock market's benchmark SMI drifted down and then stayed weak right through the trading session on Wednesday, with investors digesting corporate earnings updates and looking ahead to the Federal Reserve's rate decision due later in the day.
RTTNews | 2h 43min ago
Fed Announces Widely Expected Decision To Cut Rates By Another Quarter Point

Fed Announces Widely Expected Decision To Cut Rates By Another Quarter Point

After cutting interest rates for the first time this year in September, the Federal Reserve on Wednesday announced its widely expected decision to lower rates by another quarter point. The Fed said it decided to lower the target range for the federal funds rate by 25 basis points to 3.75 percent to 4.0 percent in support of its dual goals.
RTTNews | 3h 10min ago
Major European Markets Close On Mixed Note Ahead Of Fed Rate Decision

Major European Markets Close On Mixed Note Ahead Of Fed Rate Decision

European stocks turned in a mixed performance on Wednesday with investors reacting to a slew of earnings announcements, and looking ahead to the monetary policy announcement from the Federal Reserve later in the day, and the upcoming meeting between U.S. President Donald Trump and his Chinese counterpart Xi Jinping. Investors also looked ahead to the ECB's policy announcement due tomorrow.
RTTNews | 3h 12min ago
Canadian Market Drifts Lower After BoC Rate Decision; Energy, Materials Shares Rise

Canadian Market Drifts Lower After BoC Rate Decision; Energy, Materials Shares Rise

The Canadian market is down in negative territory around noon on Wednesday, weighed down by losses in consumer, healthcare, industrials and real estate sectors. Investors are digesting the Bank of Canada's rate cut decision, and looking ahead to the Federal Reserve's interest rate announcement due later in the day.
RTTNews | 5h 20min ago
U.S. Pending Home Sales Unexpectedly Unchanged In September

U.S. Pending Home Sales Unexpectedly Unchanged In September

After reporting a sharp increase by pending home sales in the U.S. in the previous month, the National Association of Realtors released a report on Wednesday showing pending home sales unexpectedly came in flat in the month of September. NAR said its pending homes sales index was unchanged at 74.8 in September after surging by 4.2 percent in August.
RTTNews | 7h 24min ago
Bank Of Canada Cuts Interest Rates By Another Quarter Point

Bank Of Canada Cuts Interest Rates By Another Quarter Point

The Bank of Canada on Wednesday announced its widely expected decision to lower interest rates once again, cutting rates by a quarter point for the second consecutive meeting. The Canadian central bank said it reduced its target for the overnight rate by 25 basis points to 2.25 percent, with the Bank Rate at 2.5 percent and the deposit rate at 2.20 percent.
RTTNews | 7h 26min ago